Binding Constants of Clinical Drugs and Other Organic Ligands with Human and Mammalian Serum Albumins
Open Access
- 8 September 2021
- journal article
- research article
- Published by MDPI AG in Biophysica
- Vol. 1 (3) , 344-358
Abstract
A dataset containing the experimental values of the equilibrium binding constants of clinical drugs, and some other organic ligands with human and mammalian (predominantly bovine) serum albumins, is assembled. The affinity of drugs to albumin governs their pharmacokinetic properties, related to permeability through physiological barriers and distribution within the organism. The dataset contains 1755 records gathered from 346 original literature sources describing the albumin affinity of 324 different substances. The data were extracted from both articles and existing protein-binding databases applied strict data selection rules in order to exclude the values influenced by the third-party compounds. The dataset provides the details on the experimental conditions of the measurements, such as temperature; protein and ligand concentrations; buffer pH, composition and concentration; and the method and model used for the binding constant calculations. Analysis of the data reveals discrepancies between the values from different studies, as well as the significant influence of the measurement method. Averaging the values from multiple independent measurements from the dataset may help to determine the reliable values of the binding constants. The dataset can be used as the reference dataset for the development of predictive models to calculate binding constants, and as the choice for the experimental setup in the future albumin-binding studies.Keywords
Funding Information
- Russian Science Foundation (19-73-00209)
This publication has 85 references indexed in Scilit:
- Identification, Characterization, and Implications of Species-Dependent Plasma Protein Binding for the Oral Hedgehog Pathway Inhibitor Vismodegib (GDC-0449)Journal of Medicinal Chemistry, 2011
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysisNephrology Dialysis Transplantation, 2008
- Binding interaction of indomethacin with human serum albuminJournal of Pharmaceutical and Biomedical Analysis, 2008
- New Approach To Measure Protein Binding Based on a Parallel Artificial Membrane Assay and Human Serum AlbuminJournal of Medicinal Chemistry, 2008
- Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: Application to adaptor protein complexes in cell signalingProtein Science, 2007
- Structural Basis of the Drug-binding Specificity of Human Serum AlbuminJournal of Molecular Biology, 2005
- Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albuminJournal of Pharmaceutical and Biomedical Analysis, 2005
- Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.Journal of Pharmacobio-Dynamics, 1980
- An in vitro model of drug/drug interaction at albumin binding sitesJournal of Pharmacological Methods, 1979